by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
Australian Journal of Pharmacy : February 2005
Leave the Red Zone • NEW topical treatment for mild to moderate rosacea1 • Superior long- term effi cacy over metronidazole gel 2 • Proven tolerability and long- term safety 1 azelaic acid 15% gel References: 1. Approved Product Information. 2. Elewski B et al. Arch Dermatol 2003; 139: 1444-1450. Indications: Azelaic acid 15% gel. Papulo-pustular rosacea. Contraindications: Hypersensitivity to any ingredient. Precautions: For external use only; avoid contact with eyes. In case of eye contact, immediately rinse with copious amounts of water; Pregnancy; Lactation; Children. Adverse Reactions: Local skin irritation (burning, pruritis, stinging/tingling, erythema, irritation, dry skin, scaling, rash) at the start of treatment, (usually regresses during course of treatment), where marked irritation persists frequency of use should be reduced to one application per day or alternatively temporarily discontinue. Uncommonly: contact dermatitis, acne, folliculitis, skin discolouration or temporary skin depigmentation (especially in people with darker skin). Very rarely; allergic skin reactions. Use in pregnancy. Category B1. Use in lactation. Negligible transfer of azelaic acid to infant via breast milk; however as low toxicity, risk not expected. FINACEA. Dose: Apply sparingly to affected areas twice a day (morning and night). Massage gently into the skin until vanishing. 2.5cm strip of gel is sufficient for the entire facial area. Pack: 30 g tubes. Poisons Schedule 2. Schering Pty Limited, ABN 50 000 023 361, Locked Bag 4, Alexandria, NSW 1435. Distributors for Schering AG, Germany. AU 2005.0012 G476 01.05